abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Artigo

30 Nov 2006

Author:
Interfaith Center on Corporate Responsibility [USA]

[PDF] Benchmarking AIDS: 2006 Year End Update

Pharmaceutical companies continue to fall short on providing access to essential medicines... However, investors found that some companies have taken steps towards improving public health in poor countries and protecting long-term shareholder value... [Includes recent steps by Abbott, Gilead, GlaxoSmithKline, Novartis, and Roche and recommendations for next steps for each of these companies.]

Linha do tempo